- Stocks
- Healthcare
- NASDAQ: MASI

Price (delayed)

$172.88

Market cap

$9.09B

P/E Ratio

64.51

Dividend/share

N/A

EPS

$2.68

Enterprise value

$9.83B

Masimo is an American manufacturer of noninvasive patient monitoring technologies based in Irvine, California. The company sells pulse oximetry to hospitals. Masimo was founded in 1989 by electrical engineer Joe

Masimo's revenue has soared by 78% YoY and by 23% from the previous quarter

The gross profit has grown by 43% YoY and by 18% from the previous quarter

Masimo's equity has decreased by 14% YoY but it has increased by 7% QoQ

The company's quick ratio has shrunk by 71% YoY

MASI's P/E is 52% above its last 4 quarters average of 42.4 and 42% above its 5-year quarterly average of 45.4

What are the main financial stats of MASI

Market
Valuations
Earnings

Shares outstanding

52.6M

Market cap

$9.09B

Enterprise value

$9.83B

Price to earnings (P/E)

64.51

Price to book (P/B)

6.79

Price to sales (P/S)

4.55

EV/EBIT

50.84

EV/EBITDA

29.84

EV/Sales

4.83

Revenue

$2.04B

EBIT

$193.4M

EBITDA

$329.5M

Free cash flow

-$23.4M

Per share
Balance sheet
Liquidity

EPS

$2.68

Free cash flow per share

-$0.44

Book value per share

$25.47

Revenue per share

$37.98

TBVPS

$38.11

Total assets

$3.21B

Total liabilities

$1.87B

Debt

$941.6M

Equity

$1.34B

Working capital

$678.6M

Debt to equity

0.7

Current ratio

2.08

Quick ratio

1.03

Net debt/EBITDA

2.24

Margins
Efficiency
Dividend

EBITDA margin

16.2%

Gross margin

52%

Net margin

7%

Operating margin

10.3%

Return on assets

5.2%

Return on equity

10.7%

Return on invested capital

11.2%

Return on capital employed

7.5%

Return on sales

9.5%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Masimo stock price performed over time

Intraday

-0.88%

1 week

0.67%

1 month

4.09%

1 year

10.31%

YTD

16.85%

QTD

16.85%

How have Masimo's revenue and profit performed over time

Revenue

$2.04B

Gross profit

$1.06B

Operating income

$210M

Net income

$143.5M

Gross margin

52%

Net margin

7%

Masimo's revenue has soared by 78% YoY and by 23% from the previous quarter

MASI's net margin has dropped by 67% year-on-year and by 36% since the previous quarter

Masimo's operating margin has shrunk by 54% YoY and by 13% QoQ

The gross profit has grown by 43% YoY and by 18% from the previous quarter

What is Masimo's growth rate over time

What is Masimo stock price valuation

P/E

64.51

P/B

6.79

P/S

4.55

EV/EBIT

50.84

EV/EBITDA

29.84

EV/Sales

4.83

MASI's P/E is 52% above its last 4 quarters average of 42.4 and 42% above its 5-year quarterly average of 45.4

The EPS has contracted by 39% YoY and by 20% from the previous quarter

The stock's price to book (P/B) is 17% more than its last 4 quarters average of 5.8 but 12% less than its 5-year quarterly average of 7.7

Masimo's equity has decreased by 14% YoY but it has increased by 7% QoQ

Masimo's revenue has soared by 78% YoY and by 23% from the previous quarter

The price to sales (P/S) is 47% lower than the 5-year quarterly average of 8.6 and 13% lower than the last 4 quarters average of 5.2

How efficient is Masimo business performance

Masimo's ROIC has plunged by 70% YoY and by 25% from the previous quarter

The return on assets has dropped by 63% year-on-year and by 30% since the previous quarter

The ROS has plunged by 59% YoY and by 23% from the previous quarter

MASI's return on equity is down by 36% year-on-year and by 18% since the previous quarter

What is MASI's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for MASI.

How did Masimo financials performed over time

MASI's total assets is 72% greater than its total liabilities

The company's quick ratio has shrunk by 71% YoY

MASI's total assets has surged by 70% year-on-year and by 5% since the previous quarter

MASI's debt is 30% smaller than its equity

Masimo's equity has decreased by 14% YoY but it has increased by 7% QoQ

The debt to equity has declined by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.